Vivos (RDGL) Return on Sales Growth (1y) (2011 - 2025)
Vivos (RDGL) Return on Sales Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 0.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 0.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 0.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 0.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 0.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.00 |
| 10 | Vivos | 22.64 Mn | 21.08 Mn | -3,105.00 | 161.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 161.00 |
| Sep 30, 2025 | -105.00 |
| Jun 30, 2025 | -6.00 |
| Mar 31, 2025 | 93.00 |
| Dec 31, 2024 | -56.00 |
| Sep 30, 2024 | -70.00 |
| Jun 30, 2024 | 102.00 |
| Mar 31, 2024 | -83.00 |
| Dec 31, 2023 | -40.00 |
| Sep 30, 2023 | -53.00 |
| Jun 30, 2023 | -64.00 |
| Mar 31, 2023 | 12.00 |
| Dec 31, 2022 | 7.00 |
| Sep 30, 2022 | -29.00 |
| Dec 31, 2021 | -57.00 |
| Sep 30, 2021 | 6.00 |
| Dec 31, 2020 | 278.00 |
| Sep 30, 2020 | 64.00 |
| Dec 31, 2017 | -773.00 |
| Sep 30, 2017 | -826.00 |